Covered recipient · General Payments record
LEON BARKODAR
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$19,214.77
- Reported across 211 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $658.65 | 25 |
| Education | $13.11 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $192.83 | 10 |
| Medtronic, Inc. | $127.17 | 1 |
| PFIZER INC. | $76.43 | 4 |
| Abbott Laboratories | $65.86 | 1 |
| Biogen, Inc. | $36.95 | 2 |
| Neurelis, Inc. | $34.37 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $33.07 | 1 |
| Teva Pharmaceuticals USA, Inc. | $29.92 | 1 |
| ARGENX US, INC. | $24.66 | 1 |
| EISAI INC. | $20.07 | 1 |
| UCB, Inc. | $17.32 | 1 |
| Amgen Inc. | $13.11 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $65.86 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125255549 | CMS |
| ABBVIE INC. | $34.74 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280467 | CMS |
| ABBVIE INC. | $10.63 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280469 | CMS |
| ABBVIE INC. | $10.06 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280471 | CMS |
| ABBVIE INC. | $11.08 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280473 | CMS |
| ABBVIE INC. | $19.85 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280475 | CMS |
| ABBVIE INC. | $26.48 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280477 | CMS |
| ABBVIE INC. | $14.79 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280479 | CMS |
| ABBVIE INC. | $18.91 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280481 | CMS |
| ABBVIE INC. | $21.98 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280483 | CMS |
| ABBVIE INC. | $24.31 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103280485 | CMS |
| Amgen Inc. | $13.11 | 02/23/2024 | Education | Undisputed | 01/23/2026 | 1111524800 | CMS |
| ARGENX US, INC. | $24.66 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142111107 | CMS |
| Biogen, Inc. | $18.35 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104871352 | CMS |
| Biogen, Inc. | $18.60 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104828804 | CMS |
| Eisai Inc. | $20.07 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110760296 | CMS |
| Medtronic, Inc. | $127.17 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119473633 | CMS |
| Neurelis, Inc. | $14.89 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145633058 | CMS |
| Neurelis, Inc. | $19.48 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145633062 | CMS |
| Novartis Pharmaceuticals Corporation | $33.07 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086768447 | CMS |
| PFIZER INC. | $25.68 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131105284 | CMS |
| PFIZER INC. | $15.57 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131151795 | CMS |
| PFIZER INC. | $14.17 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131151799 | CMS |
| PFIZER INC. | $21.01 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131223066 | CMS |
| Teva Pharmaceuticals USA, Inc. | $29.92 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151581135 | CMS |
| UCB, Inc. | $17.32 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143058092 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.